HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rainey, W. E. Articles by Saez, J. M. Search for Related Content PubMed PubMed Citation Articles by Rainey, W. E. Articles by Saez, J. M. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 264, Issue 36, 21474-21477, 12, 1989

Transforming growth factor beta treatment decreases ACTH receptors on ovine adrenocortical cells

WE Rainey, I Viard and JM Saez
Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas 75235.

Transforming growth factor beta (TGF beta) is a potent inhibitor of adrenocortical cell differentiated functions, whereas corticotropin (ACTH) is the main physiological hormone which acts positively on these functions. We have studied the effects of both TGF beta and ACTH on ovine adrenocortical cell ACTH receptors. Ovine adrenocortical cells contained specific high affinity (Kd = 2.7 +/- 1.6 x 10(-10) M) and low capacity (1190 +/- 120 sites/cell) ACTH receptors. Pretreatment of cells with TGF beta resulted in a time- and dose-dependent (ED50 = 50 pg/ml) decrease of 125I-ACTH1-39 binding. The observed decrease in ACTH binding was due to a 2-3-fold decrease in the number of binding sites without modification of the binding affinity. On the contrary, pretreatment of cells with ACTH caused a 4-4.5-fold increase in the number of ACTH binding sites without an effect on the Kd. When cells were pretreated with both ACTH and TGF beta, TGF beta blocked completely the positive trophic effect of ACTH on its own receptors. The variations in ACTH receptor number were associated with parallel changes on acute ACTH-induced cyclic AMP production. Thus, the effects of TGF beta on ACTH receptor content are likely another important negative action of this peptide on adrenocortical cell differentiation. Moreover, these results suggest that regulation of ACTH receptor number may be one mechanism by which hormones and growth factors control adrenocortical differentiation.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				K. S. Rehman, R. Sirianni, C. R. Parker JR, W. E. Rainey, and B. R. Carr The Regulation of Adrenocorticotrophic Hormone Receptor by Corticotropin-Releasing Hormone in Human Fetal Adrenal Definitive/Transitional Zone Cells Reproductive Sciences, September 1, 2007; 14(6): 578 - 587. [Abstract] [PDF]

				C. Le Roy, J. Y. Li, D. M. Stocco, D. Langlois, and J. M. Saez Regulation by Adrenocorticotropin (ACTH), Angiotensin II, Transforming Growth Factor-{beta}, and Insulin-Like Growth Factor I of Bovine Adrenal Cell Steroidogenic Capacity and Expression of ACTH Receptor, Steroidogenic Acute Regulatory Protein, Cytochrome P450c17, and 3{beta}-Hydroxysteroid Dehydrogenase Endocrinology, May 1, 2000; 141(5): 1599 - 1607. [Abstract] [Full Text] [PDF]

				G. W. Wolkersdörfer, T. Lohmann, C. Marx, S. Schröder, R. Pfeiffer, H.-D. Stahl, W. A. Scherbaum, G. P. Chrousos, and S. R. Bornstein Lymphocytes Stimulate Dehydroepiandrosterone Production through Direct Cellular Contact with Adrenal Zona Reticularis Cells: A Novel Mechanism of Immune-Endocrine Interaction J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4220 - 4227. [Abstract] [Full Text]

				L. J. Rosolowsky, C. J. Hanke, and W. B. Campbell Adrenal Capillary Endothelial Cells Stimulate Aldosterone Release through a Protein That Is Distinct from Endothelin Endocrinology, October 1, 1999; 140(10): 4411 - 4418. [Abstract] [Full Text]

				M. Ehrhart-Bornstein, J. P. Hinson, S. R. Bornstein, W. A. Scherbaum, and G. P. Vinson Intraadrenal Interactions in the Regulation of Adrenocortical Steroidogenesis Endocr. Rev., April 1, 1998; 19(2): 101 - 143. [Abstract] [Full Text]

				M. G. Leavitt, G. W. Aberdeen, M. G. Burch, E. D. Albrecht, and G. J. Pepe Inhibition of Fetal Adrenal Adrenocorticotropin Receptor Messenger Ribonucleic Acid Expression by Betamethasone Administration to the Baboon Fetus in Late Gestation Endocrinology, July 1, 1997; 138(7): 2705 - 2712. [Abstract] [Full Text] [PDF]

				S. Mesiano and R. B. Jaffe Developmental and Functional Biology of the Primate Fetal Adrenal Cortex Endocr. Rev., June 1, 1997; 18(3): 378 - 403. [Abstract] [Full Text]

				Y.-K. Yang, M. M. Ollmann, B. D. Wilson, C. Dickinson, T. Yamada, G. S. Barsh, and I. Gantz Effects of Recombinant Agouti-Signaling Protein on Melanocortin Action Mol. Endocrinol., March 1, 1997; 11(3): 274 - 280. [Abstract] [Full Text]

				C. Le Roy, P. Leduque, P. M. Dubois, J. M. Saez, and D. Langlois Repression of Transforming Growth Factor beta1 Protein by Antisense Oligonucleotide-induced Increase of Adrenal Cell Differentiated Functions J. Biol. Chem., May 3, 1996; 271(18): 11027 - 11033. [Abstract] [Full Text] [PDF]